CARL HARRISON: Open Payments
NPI 1073005989 · ABINGDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$848 in 25 payments from 7 companies in 2025. Trend: 2023 $1,096 · 2024 $214 · 2025 $848
Food & beverage: $848
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $461 |
| Otsuka America Pharmaceutical, Inc. | 3 | $164 |
| Lundbeck LLC | 4 | $95 |
| Alkermes, Inc. | 4 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: COBENFY, REXULTI, ABILIFY MAINTENA, ARISTADA, CAPLYTA, VRAYLAR, AUSTEDO XR.
Industry payments across VA — which companies pay providers there.
